T. Rowe Price Investment Management
VERA icon

T. Rowe Price Investment Management’s Vera Therapeutics VERA Stock Holding History

T. Rowe Price Investment Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,675,367
Closed -$40.2M – 738
2025
Q1 		$40.2M Buy
1,675,367
+260,188
+18% +$8.36M 0.03% 432
2024
Q4 		$59.8M Buy
1,415,179
+431,178
+44% +$19.1M 0.04% 380
2024
Q3 		$43.5M Buy
+984,001
New +$37.3M 0.03% 424

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

T. Rowe Price Investment Management's VERA Position: Q2 2025 in Review

T. Rowe Price Investment Management sold out of Vera Therapeutics (VERA) in Q2 2025, closing a stake of 1,675,367 shares — an estimated $40.2M sold.

T. Rowe Price Investment Management first reported a position in VERA in Q3 2024 and held it in 3 quarters. The position peaked at $59.8M in Q4 2024. 172 funds tracked by Wall St. Rank hold VERA as of Q2 2025.

  • T. Rowe Price Investment Management reported no remaining Vera Therapeutics position as of Q2 2025 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 1,675,367 Vera Therapeutics shares in Q2 2025, an estimated $40.2M.
  • T. Rowe Price Investment Management first reported a position in Vera Therapeutics in Q3 2024 and held it in 3 quarters.
  • T. Rowe Price Investment Management's Vera Therapeutics position peaked at $59.8M in Q4 2024.
  • 172 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2025.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.